267 related articles for article (PubMed ID: 31734720)
1. Corticosteroids usage and central serous chorioretinopathy: a meta-analysis.
Ge G; Zhang Y; Zhang Y; Xu Z; Zhang M
Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):71-77. PubMed ID: 31734720
[TBL] [Abstract][Full Text] [Related]
2. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy.
Zavoloka O; Bezditko P; Lahorzhevska I; Zubkova D; Ilyina Y
Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1737-42. PubMed ID: 26979068
[TBL] [Abstract][Full Text] [Related]
4. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
Dysli C; Berger L; Wolf S; Zinkernagel MS
Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
[TBL] [Abstract][Full Text] [Related]
5. CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.
Honda S; Miki A; Kusuhara S; Imai H; Nakamura M
Retina; 2017 Aug; 37(8):1562-1567. PubMed ID: 27787451
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Takayama K; Obata H; Takeuchi M
Ocul Immunol Inflamm; 2020 Apr; 28(3):509-512. PubMed ID: 31268769
[No Abstract] [Full Text] [Related]
7. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
8. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
Matušková V; Vysloužilová D; Uher M
Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
[TBL] [Abstract][Full Text] [Related]
9. Central Serous Chorioretinopathy.
Daruich A; Matet A; Behar-Cohen F
Dev Ophthalmol; 2017; 58():27-38. PubMed ID: 28351043
[TBL] [Abstract][Full Text] [Related]
10. TWELVE-MONTH EFFICACY OF INTRAVITREAL BEVACIZUMAB INJECTION FOR CHRONIC, ATYPICAL, OR RECURRENT CENTRAL SEROUS CHORIORETINOPATHY.
Chung YR; Kim JW; Song JH; Park A; Kim MH
Retina; 2019 Jan; 39(1):134-142. PubMed ID: 29077604
[TBL] [Abstract][Full Text] [Related]
11. INSTRUMENTAL DIFFERENCE IN ASSESSING CHOROIDAL HYPERPERMEABILITY AND PHOTODYNAMIC THERAPY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Lee SM; Kwon HJ; Park SW; Lee JE; Byon IS
Retina; 2019 Jul; 39(7):1361-1369. PubMed ID: 29554076
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
13. Central serous chorioretinopathy mimicking as choroiditis.
Panigrahi PK; Mahapatra MM; Minj A; Satapathy J; Samant S
Clin Exp Optom; 2018 May; 101(3):420-421. PubMed ID: 29134698
[No Abstract] [Full Text] [Related]
14. Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.
Chan SY; Pan CT; Wang Q; Shi XH; Jonas JB; Wei WB
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1365-1372. PubMed ID: 31037490
[TBL] [Abstract][Full Text] [Related]
15. Effect of Serous Retinal Detachment on the Measurement of Axial Length in Central Serous Chorioretinopathy.
Shin YI; Won YK; Shin KS; Jo YJ; Kim JY
Korean J Ophthalmol; 2019 Feb; 33(1):63-69. PubMed ID: 30746913
[TBL] [Abstract][Full Text] [Related]
16. Fundus autofluorescence and visual acuity in central serous chorioretinopathy.
Imamura Y; Fujiwara T; Spaide RF
Ophthalmology; 2011 Apr; 118(4):700-5. PubMed ID: 21055816
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
Son BK; Kim K; Kim ES; Yu SY
Ophthalmologica; 2019; 241(2):105-115. PubMed ID: 30110697
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.
Çiloğlu E; Unal F; Dogan NC
Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1111-1116. PubMed ID: 29671064
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of photodynamic therapy in steroid-associated chronic central serous chorioretinopathy: a case-control study.
Breukink MB; Mohabati D; van Dijk EH; den Hollander AI; de Jong EK; Dijkman G; Keunen JE; Hoyng CB; Boon CJ
Acta Ophthalmol; 2016 Sep; 94(6):565-72. PubMed ID: 27149889
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic central serous chorioretinopathy.
Hanumunthadu D; Tan ACS; Singh SR; Sahu NK; Chhablani J
Indian J Ophthalmol; 2018 Dec; 66(12):1704-1714. PubMed ID: 30451170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
